PRKG1 and cardiac hypertrophy: Additionally, after 8 weeks of TAC, Maresin1 alleviated PO‐induced cardiac hypertrophy and fibrosis, and promoted the deubiquitination and stabilization of PPARα through the PKG/CREB1/USP4 pathway (Figure S19C–H, Supporting Information).